Page last updated: 2024-10-23

aspirin and alpha-Galactosidase A Deficiency

aspirin has been researched along with alpha-Galactosidase A Deficiency in 4 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"Fabry disease is caused by a deficiency of lysosomal alpha galactosidase and has a very large genotypic and phenotypic spectrum."1.72Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones. ( Allocca, M; Andreotti, G; Bosso, A; Cubellis, MV; Hay Mele, B; Liguori, L; Lukas, J; Monti, MC; Monticelli, M; Morretta, E, 2022)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Monticelli, M1
Liguori, L1
Allocca, M1
Bosso, A1
Andreotti, G1
Lukas, J1
Monti, MC1
Morretta, E1
Cubellis, MV1
Hay Mele, B1
Hollander, Z1
Dai, DL1
Putko, BN1
Yogasundaram, H1
Wilson-McManus, JE1
Thompson, RB1
Khan, A1
West, ML1
McManus, BM1
Oudit, GY1
Tchan, M1
Sillence, D1
Hughes, DA1
Mehta, AB1

Reviews

1 review available for aspirin and alpha-Galactosidase A Deficiency

ArticleYear
Vascular complications of Fabry disease: enzyme replacement and other therapies.
    Acta paediatrica (Oslo, Norway : 1992). Supplement, 2005, Volume: 94, Issue:447

    Topics: alpha-Galactosidase; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blood Coagulati

2005

Other Studies

3 other studies available for aspirin and alpha-Galactosidase A Deficiency

ArticleYear
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones.
    International journal of molecular sciences, 2022, May-04, Volume: 23, Issue:9

    Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Aspirin; Drug Repositioning; Fabry Disease; Humans; Lysosom

2022
Gender-specific plasma proteomic biomarkers in patients with Anderson-Fabry disease.
    European journal of heart failure, 2015, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; alpha-Galactosidase; Aspirin; Biomarkers; Blood Proteins; Cerebrovascular D

2015
Fabry disease and Factor V Leiden: a potent vascular risk combination.
    Internal medicine journal, 2011, Volume: 41, Issue:5

    Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defib

2011